CTI BioPharma
CTIC
#5743
Rank
NZ$2.00 B
Marketcap
NZ$15.20
Share price
0.00%
Change (1 day)
25.81%
Change (1 year)

CTI BioPharma (CTIC) - Net assets

Net assets on the balance sheet as of March 2023 : -NZ$42.4 Million

According to CTI BioPharma 's latest financial reports the company has -NZ$42.4 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

CTI BioPharma - Net assets on balance sheet (from 2001 to 2023)

Net assets by year

Year Net assets Change
2022-12-31$-NZ$27.69 Million-601.99%
2021-12-31$NZ$5.51 M-90.06%
2020-12-31$NZ$55.47 M108.38%
2019-12-31$NZ$26.62 M-66.27%
2018-12-31$NZ$78.92 M248.36%
2017-12-31$NZ$22.65 M102.31%
2016-12-31$NZ$11.19 M-83.83%
2015-12-31$NZ$69.27 M41.06%
2014-12-31$NZ$49.1 M-5.62%
2013-12-31$NZ$52.03 M29.93%
2012-12-31$NZ$40.04 M11.59%
2011-12-31$NZ$35.88 M-638.13%
2010-12-31$-NZ$6.67 Million-74.19%
2009-12-31$-NZ$25.85 Million-87.87%
2008-12-31$-NZ$0.22 Billion51.29%
2007-12-31$-NZ$0.15 Billion-2.34%
2006-12-31$-NZ$0.15 Billion-7.96%
2005-12-31$-NZ$0.16 Billion58.12%
2004-12-31$-NZ$99.1 Million-21.96%
2003-12-31$-NZ$0.13 Billion-252.83%
2002-12-31$NZ$83.08 M-68.51%
2001-12-31$NZ$0.26 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
NZ$77.85 B-183,746.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
NZ$44.38 B-104,786.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$16.08 B-38,049.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$10.20 B-24,173.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$8.64 B-20,486.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$30.95 B-73,110.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$13.23 B-31,322.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel